DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Robinson JG, Farnier M, Krempf M. et al; ODYSSEY LONG TERM Investigators.
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
N Engl J Med 2015;
372 (16) 1489-1499
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.